Cancer Research Horizons

News

Bioptimus, a global AI biotech company, has announced a partnership with Cancer Research Horizons, the innovation engine of Cancer Research UK.

News

AC Immune has announced positive interim results from its Ph 1 study of ACI-19764 – a NLRP3 inflammasome inhibitor targeting chronic inflammation.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.